Recent research published by The Journal of Nuclear Medicine (JNM) has highlighted several advancements in the field of nuclear medicine and imaging. Key studies include: 1. **Kidney Cancer Metastases**: A study evaluated the effectiveness of two biomarkers, CD70 and CAIX, and a new targeted PET/CT scan, 18F-RCCB6, for identifying lung metastases in clear cell kidney cancer. 2. **Detecting ATTR Amyloidosis**: Researchers analyzed the behavior of the imaging agent 99mTc-pyrophosphate in various tissues to determine the optimal timing for scans in detecting ATTR amyloid cardiomyopathy. 3. **Radiation Therapies for Neuroendocrine Tumors**: An early-phase study compared two radiopharmaceuticals, 161Tb-DOTA-LM3 and 177Lu-DOTATOC, assessing their efficacy in delivering radiation to tumors and measuring radiation absorption in different tissues. 4. **Heart-Healing Cells Imaging**: A new PET tracer, 64Cu-LNTH-1363S, was tested in mouse models of heart attack to identify fibroblasts responsible for cardiac repair. 5. **Nuclear Medicine in Africa**: A survey examined the current state of nuclear medicine in Africa, revealing growth in PET/CT and SPECT services, along with challenges in equipment and workforce availability. 6. **Alzheimer's Detection**: A study tested three different radioactive labels attached to a bispecific antibody aimed at detecting amyloid-β in Alzheimer's model mice, showing varying levels of brain uptake and signal strength. For more details and ongoing updates, visit the JNM website or follow them on social media.
Fri, 12 Dec 2025 17:46:00 GMT | Mirage News